ASPIRIN AND DIPYRIDAMOLE DECREASE INTIMAL HYPERPLASIA IN EXPERIMENTAL VEIN GRAFTS
ASPIRIN AND DIPYRIDAMOLE DECREASE INTIMAL HYPERPLASIA IN EXPERIMENTAL VEIN GRAFTS
复制标题
DOI:
10.1097/00000658-198002000-00018
复制
发表时间:
1980-01-01
影响因子:
9
通讯作者:
FUCHS, JCA
中科院分区:
文献类型:
--
作者:
MCCANN, RL;HAGEN, PO;FUCHS, JCA
Release from platelets of a factor mitogenic for smooth muscle cells is a postulated mechanism for the pathogenesis of vascular intimal hyperplasia. The effect of antiplatelet therapy was evaluated. Aspirin (165 mg twice daily) and dipyridamole (25 mg twice daily) were administered to 6 rhesus monkeys and 6 were given placebo. Bilateral vein bypass grafts were placed in the iliac arteries. To evaluate the relative contribution of adventitial dissection and intimal injury, on 1 side the carotid artery and femoral vein were stripped of adventitia and on the other side the intima of the vessels were injured by the single passage of an inflated balloon-tipped catheter. Animals were killed after 16 wk. In grafts relative luminal area was determined by a photographic grayimetric method at 3 standard locations. Femoral veins and carotid arteries were classified as histologically normal or as exhibiting hyperplasia. All vessels with adventitial stripping were normal. All vessels with intimal injury in the placebo group except 1 exhibited intimal hyperplasia compared to the drug-treated group in which > 1/2 were normal. Relative intimal area was significantly less in grafts from drug treated animals at all 3 locations and luminal area greater in 2. Vascular intimal hyperplasia may be reduced by treatment with antiplatelet agents.